Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Eiji Yahiro"'
Autor:
Kaori Koga, Tetsuhiko Go, Mikiko Aoki, Ryuji Inoue, Hiroyasu Yokomise, Aya Yamamura, Kohtaro Abe, Katsuya Hirano, Lin Hai Kurahara, Narumi Aoki-Shoi, Sei Kobayashi, Eiji Yahiro, Satoh Toru, Hiroko Kishi, Keizo Hiraishi, Zhang Bo, Kaori Ishikawa, Ying Zhang
Publikováno v:
Journal of Molecular and Cellular Cardiology. 148:50-62
Pulmonary arterial hypertension (PAH) is a multifactorial disease characterized by pulmonary arterial vasoconstriction and remodeling. Src family tyrosine kinases, including Fyn, play critical roles in vascular remodeling via the inhibition of STAT3
Publikováno v:
Hypertension. 76
Chymase, a serine protease, has been extensively studied with respect to its role in the pathogenesis of salt-induced hypertension and is noteworthy for the generation of Angiotensin II. Studies to decipher the pathophysiological role of chymase in c
Autor:
Eiji Yahiro, Atsushi Iwata, Tomo Komaki, Satoshi Imaizumi, Takashi Kuwano, Akira Matsunaga, Yuhei Shiga, Ken Kitajima, Keijiro Saku, Natsumi Morito, Tadaaki Arimura, Shin-ichiro Miura, Kanta Fujimi, Joji Morii
Publikováno v:
Journal of Clinical Medicine Research
Background: In our experience, the change in body weight (BW) during hospitalization varies greatly in patients with acute decompensated heart failure (HF). Since the clinical significance of a change in BW is not clear, we investigated whether a cha
Autor:
Shin-ichiro Miura, Keijiro Saku, Yoshinari Uehara, Takashi Kuwano, Yasunori Suematsu, Satoshi Imaizumi, Eiji Yahiro
Publikováno v:
CardioMetabolic Syndrome Journal. 1:135
Autor:
Kohei Takata, Yoshino Matsuo, Keijiro Saku, Tetsuhiko Yasuno, Shin-ichiro Miura, Satomi Abe, Yoshinari Uehara, Tomohiko Shimizu, Eiji Yahiro, Bo Zhang, Shiro Jimi, Kyoko Nakajima, Yasunori Suematsu, Satoshi Imaizumi, Emi Kawachi
Publikováno v:
International Journal of Cardiology. 207:317-325
Background/objective HDL has various atheroprotective functions and improves endothelial function. Apolipoprotein A-I (apoA-I) is a major protein of HDL and plays a crucial role in HDL functions. We developed a novel apoA-I mimetic peptide, FAMP (Fuk
Autor:
Tadaaki Arimura, Yoshino Matsuo, Yasunori Suematsu, Satoshi Imaizumi, Atsushi Iwata, Eiji Yahiro, Masaki Goto, Takashi Kuwano, Shin-ichiro Miura, Keijiro Saku
Publikováno v:
European Journal of Heart Failure. 18:386-393
Aims Angiotensin receptor–neprilysin inhibitors (ARNis) acts an ARB and neprilysin inhibitor. Diabetes mellitus significantly increases the risk of cardiovascular disease and heart failure (HF). Therefore, we evaluated the effects and mechanisms of
Autor:
Atsushi Iwata, Keijiro Saku, Kanta Fujimi, Shin-ichiro Miura, Eiji Yahiro, Ken Kitajima, Natsumi Morito, Tadaaki Arimura, Yuhei Shiga, Joji Morii
Publikováno v:
Journal of Clinical Medicine Research
Background: To improve the clinical outcome of heart failure (HF), it is important to evaluate the etiology and comorbidities of HF. We previously reported the baseline clinical characteristics and medications in hospitalized patients with HF in year
Autor:
Keijiro Saku, Yoshinari Uehara, Takashi Kuwano, Yoshino Matsuo, Shin-ichiro Miura, Tomohiko Shimizu, Kohei Takata, Eiji Yahiro, Yasunori Suematsu, Satoshi Imaizumi
Publikováno v:
International Journal of Cardiology. 202:810-816
Objective We evaluated whether a novel inducible cholesterol efflux (iCE) peptide [ F ukuoka University A polipoprotein A-I M imetic P eptide (FAMP)] protects against myocardial ischemia reperfusion injury (IRI) through a nitric oxide (NO) pathway by
Autor:
Tetsuro Shirotani, Masahiro Ogawa, Natsumi Morito, Eiji Yahiro, Mikio Fukushima, Fumihiro Hoshino, Dai Shimono, Satoshi Imaizumi, Shin-ichiro Miura, Takaaki Kusumoto, Yuhei Shiga, Hidekazu Sugihara, Akira Matsunaga, Keijiro Saku, Hiroyuki Tanigawa, Kenji Norimatsu, Hideto Sako, Yoshihisa Nagata, Yuko Uehara
Publikováno v:
Heart and vessels. 34(4)
There is a lack of data on how to treat hypertensive patients with diabetes when treatment with medium doses of calcium channel blocker and angiotensin II type 1 receptor blocker (ARB) is insufficient to achieve the target blood pressure (BP). A tota
Autor:
Satoshi, Imaizumi, Yuhei, Shiga, Masahiro, Ogawa, Hideto, Sako, Yoshihisa, Nagata, Akira, Matsunaga, Tetsuro, Shirotani, Fumihiro, Hoshino, Eiji, Yahiro, Yuko, Uehara, Natsumi, Morito, Hiroyuki, Tanigawa, Dai, Shimono, Mikio, Fukushima, Hidekazu, Sugihara, Kenji, Norimatsu, Takaaki, Kusumoto, Keijiro, Saku, Shin-Ichiro, Miura
Publikováno v:
Heart and Vessels. 35:603-604
In the Original publication of the article, the legend appearing inside the flow chart has been incorrectly published.